Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II-b Randomized Study of Cabazitaxel in Metastatic Colorectal Cancer Resistant to Standard Treatment

NCT02204332 is registered in ClinicalTrials.gov with Hospital Clinico Universitario de Santiago as lead sponsor.

NCT NCT02204332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02204332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II-b Randomized Study of Cabazitaxel in Metastatic Colorectal Cancer Resistant to Standard Treatment
Lead sponsor
Hospital Clinico Universitario de Santiago
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2013
Completion date
Not reported
Enrollment
38 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer